-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - NR NR NR NR NR NR NR NR NR NR NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA Psychiatric disorders, cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - NR NR NR NR NR NR NR NR NR NR NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA Psychiatric disorders, cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - benefits would be realized only if these therapies do not pose risk of serious adverse events
(i.e., cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - Inhibition of a cardiac sarcoplasmic
reticulum chloride channel by tamoxifen.
-
effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Ergots can cause cardiac,
cerebral, or peripheral ischemia in some high risk patients.”
113
Experts
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - ranges from
$20,000 to $35,000.108 These costs generally include preoperative lab work, x-ray fees, cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
January 01, 2011 - Five-year risk of cardiac mortality in
relation to initial severity and one-year
changes in depression
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - Sorry I lost the site for this info but it was
in interesting article reviewing result
changes in the cardiac
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - Inhibition of a cardiac sarcoplasmic
reticulum chloride channel by tamoxifen.